Aimed Alliance Joins 19 Advocacy Organizations Opposing Tennessee’s Proposed Closed Formulary
On Dec. 24, 2019, Aimed Alliance joined a coalition of advocacy organizations in a letter…
Browsing: Value
Aimed Alliance Comments on ICER’s Proposed 2020 Value Assessment Framework
On October 15, 2019, Aimed Alliance submitted a comment to the Institute of Clinical and…
Aimed Alliance Submits Testimony on Cardiovascular Comparative Effectiveness Study
On September 26, 2019, Aimed Alliance delivered oral testimony on the Institute for Clinical and…
Aimed Alliance Submits Comment to ICER Regarding Comparative Effectiveness Study on Cardiovascular Treatments
On August 19, 2019, Aimed Alliance submitted a comment to the Institute for Clinical and…
Aimed Alliance Joins PIPC Sign-on Letter Requesting Changes to ICER’s Value Assessment Framework
On June 11, 2019, Aimed Alliance joined 37 other organizations in signing onto a letter…
Aimed Alliance To Moderate Panel on Future of Value Based Pricing Initiatives at 2016 FDA/CMS Summit
Aimed Alliance’s Executive Director, Stacey Worthy, will moderate a panel discussion entitled “The Future of…
Aimed Alliance To Co-Host “Voices of Value Speak Up” Panel with Patients Rising
Aimed Alliance will co-host “Voices of Value Speak Up” with Patients Rising, where patients, advocates, economists,…
Aimed Alliance Calls on Institution To Prevent Discrimination of Patients with Non-Small Cell Lung Cancer
Aimed Alliance has urged the Institute for Clinical and Economic Review (ICER) to consider patient-defined…